Enveric Biosciences, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: ENVB
Enveric Biosciences, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its shares trade on Nasdaq under the ticker ENVB. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2026.
Enveric Biosciences at a glance
What does Enveric Biosciences do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $5 million sold (2026).
Frequently asked questions about Enveric Biosciences
Where is Enveric Biosciences headquartered?
Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Enveric Biosciences do?
Enveric Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Enveric Biosciences a public company?
Yes. Enveric Biosciences, Inc. trades on Nasdaq under the ticker ENVB.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences